LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
3.1623
7.01 17.25 913 389 2.3440 1.4171
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
7.01 17.25 1 389 0.0026 -0.4692
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
7.01 17.25 868 389 2.2285 1.3901
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
8.98 17.25 1 445 0.0022 -0.4552
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
8.98 17.25 933 445 2.0963 1.3420
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
8.98 17.25 7 445 0.0157 -0.1750
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
8.98 17.25 902 445 2.0266 1.3252
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
10.95 17.25 1 471 0.0021 -0.4494
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
10.95 17.25 958 471 2.0315 1.3202
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
10.95 17.25 15 471 0.0318 -0.0289
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
10.95 17.25 924 471 1.9594 1.3027
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
12.91 17.25 1 494 0.0020 -0.4446
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
12.91 17.25 962 494 1.9440 1.2943
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
12.91 17.25 15 494 0.0303 -0.0285
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
12.91 17.25 939 494 1.8975 1.2829
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
14.88 17.25 1 534 0.0019 -0.4373
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
14.88 17.25 963 534 1.8019 1.2525
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
14.88 17.25 11 534 0.0206 -0.0869
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
14.88 17.25 962 534 1.8001 1.2520
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
16.85 17.25 1 655 0.0015 -0.4188
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
16.85 17.25 971 655 1.4812 1.1554
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
16.85 17.25 84 655 0.1281 0.3521
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
16.85 17.25 972 655 1.4827 1.1559
MN20160310_N02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
18.82 17.25 1 800 0.0012 -0.4022
MN20160310_N02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
18.82 17.25 992 800 1.2392 1.0790
MN20160310_N02
J14